awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43078724-3EBAE3C5-C7EC-4298-AF68-C3DEC5B5A022
Q43078724-3EBAE3C5-C7EC-4298-AF68-C3DEC5B5A022
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43078724-3EBAE3C5-C7EC-4298-AF68-C3DEC5B5A022
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.
P2860
Q43078724-3EBAE3C5-C7EC-4298-AF68-C3DEC5B5A022
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43078724-3EBAE3C5-C7EC-4298-AF68-C3DEC5B5A022
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1774f3a880eb441801817234b795f4d725f0d0ad
P2860
Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris.